...
首页> 外文期刊>Journal of Medicinal Chemistry >Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer
【24h】

Fragment-Based Discovery of an Apolipoprotein E4 (apoE4) Stabilizer

机译:基于片段的载脂蛋白E4(APOE4)稳定剂的发现

获取原文
获取原文并翻译 | 示例
           

摘要

Apolipoprotein E is a 299-residue lipid carrier protein produced in both the liver and the brain. The protein has three major isoforms denoted apoE2, apoE3, and apoE4 which differ at positions 112 and 158 and which occur at different frequencies in the human population. Genome-wide association studies indicate that the possession of two apoE4 alleles is a strong genetic risk factor for late-onset Alzheimer's disease (LOAD). In an attempt to identify a small molecule stabilizer of apoE4 function that may have utility as a therapy for Alzheimer's disease, we carried out an NMR-based fragment screen on the N-terminal domain of apoE4 and identified a benzyl amidine based fragment binder. In addition to NMR, binding was characterized using various other biophysical techniques, and a crystal structure of the bound core was obtained. Core elaboration ultimately yielded a compound that showed activity in an IL-6 and IL-8 cytokine release assay.
机译:载脂蛋白E是在肝脏和脑中产生的299-残基脂质载体蛋白。 蛋白质具有三个主要同种型,其表示在112和158处的位置112和158处不同的ApoE2,ApoE3和ApoE4,并且在人群中的不同频率发生。 基因组 - 范围的协会研究表明,两个APOE4等位基因的拥有是晚期疾病(载荷)的强大遗传危险因素。 为了试图鉴定APOE4功能的小分子稳定剂,其可能具有效用作为阿尔茨海默病的疗法,我们在ApoE4的N-末端结构域上进行了基于NMR的片段筛网,并鉴定了基于苄酰胺的片段粘合剂。 除了NMR之外,使用各种其他生物物理技术表征结合,并获得结合芯的晶体结构。 核心阐述最终产生了一种在IL-6和IL-8细胞因子释放测定中显示活性的化合物。

著录项

  • 来源
    《Journal of Medicinal Chemistry》 |2019年第8期|共11页
  • 作者单位

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Deutschland GmbH &

    Co KG Neurosci Res Knollstr D-67061 Ludwigshafen Germany;

    AbbVie Deutschland GmbH &

    Co KG Neurosci Res Knollstr D-67061 Ludwigshafen Germany;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Deutschland GmbH &

    Co KG Neurosci Res Knollstr D-67061 Ludwigshafen Germany;

    AbbVie Deutschland GmbH &

    Co KG Neurosci Res Knollstr D-67061 Ludwigshafen Germany;

    AbbVie Deutschland GmbH &

    Co KG Neurosci Res Knollstr D-67061 Ludwigshafen Germany;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Neurosci Res 200 Sydney St Cambridge MA 02139 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

    AbbVie Res &

    Dev 1 North Waukegan Rd N Chicago IL 60064 USA;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号